Click a link below to view the mailing archive as if it had been sent to you.
| 2021-06-30 12:15 | | Patient experience data in regulatory decisions: Questions abound in first FDA report and more... |
| 2021-06-30 00:15 | | Sanofi commits $476M a year to mRNA vaccine center in race to expand tech beyond COVID-19 and more... |
| 2021-06-29 12:15 | | FDA and Biogen discussed Aduhelm's accelerated approval as early as 2019 — report and more... |
| 2021-06-29 00:15 | | AskBio, Syndax and Catalyst All on the Fast Track and more... |
| 2021-06-28 12:15 | | Biopharma M&A set for a strong H2 despite political noise—and Biogen and Gilead look like buyers: analysts and more... |
| 2021-06-28 00:15 | | ADA 2021: Novo trumpets higher-dose Ozempic data as Lilly competitors loom and more... |
| 2021-06-27 12:15 | | Johnson & Johnson confirms opioid business has ended in $230 million settlement with New York and more... |
| 2021-06-27 00:15 | | How a New Class of Cancer Drug Could Stop Future Coronaviruses |
| 2021-06-26 00:15 | | ADA 2021: AstraZeneca touts Bydureon trial win in children and adolescents with type 2 diabetes and more... |
| 2021-06-25 12:15 | | AbbVie (ABBV) Announces FDA Will Not Meet PDUFA Action Dates for RINVOQ sNDAs and more... |
| 2021-06-25 00:15 | | CDC advisory panel backs use of dengue vaccine in high-risk areas, despite delivery challenges and more... |
| 2021-06-24 12:15 | | As GSK, Aurinia heat up the lupus nephritis category, analyst gauges doctors' first impressions and more... |
| 2021-06-24 00:15 | | Four New Biotechs Launch to Combat MD, NASH, Parkinson's and More and more... |
| 2021-06-23 12:15 | | COVID-fighting llamas inspire 'nanobody' treatments to tackle emerging variants and more... |
| 2021-06-23 00:15 | | FDA documents show how controversial Alzheimer's drug decision was reached and more... |
| 2021-06-22 12:15 | | DEEP DIVE Legacy medical devices, growing hacker threats create perfect storm of cybersecurity risks and more... |
| 2021-06-22 00:15 | | U.S. Supreme Court rebuffs AbbVie appeal in patent fight involving AndroGel drug and more... |
| 2021-06-21 12:15 | | 8 key clinical trials to watch for the rest of 2021 and more... |
| 2021-06-21 00:15 | | What have we learned about accelerating drug development from Covid-19? and more... |
| 2021-06-18 12:15 | | Supreme Court upholds ACA, dismissing constitutional challenge and more... |
| 2021-06-18 00:15 | | Device Makers Have Funneled Billions to Orthopedic Surgeons Who Use Their Products and more... |
| 2021-06-17 12:15 | | Novartis sets the tone for the radiopharma push with a prized acquisition winning breakthrough therapy designation and more... |
| 2021-06-17 00:15 | | First patient receives controversial Biogen Alzheimer's drug and more... |
| 2021-06-16 12:15 | | Public Citizen demands removal of top FDA officials over Biogen Alzheimer's approval and more... |
| 2021-06-16 00:15 | | Slashing 186 jobs, Novartis hands off U.S. sales, marketing duties for migraine med Aimovig to Amgen and more... |
| 2021-06-15 12:15 | | Despite controversy, Biogen's Aduhelm is already generating enthusiasm among doctors: survey and more... |
| 2021-06-15 00:15 | | FDA launches global Generic Drug Cluster and more... |
| 2021-06-14 12:15 | | Novavax says vaccine 90% effective against COVID-19 in large trial and more... |
| 2021-06-14 00:15 | | Forget Biogen: These 2 Under-the-Radar Biotechs Are Also Celebrating Breakthroughs and more... |
| 2021-06-13 00:15 | | FDA panel split on approach to COVID-19 vaccines for younger children and more... |
| 2021-06-12 00:15 | | The F.D.A. tells Johnson & Johnson that about 60 million doses made at troubled plant cannot be used. and more... |
| 2021-06-11 12:15 | | Johnson & Johnson's COVID-19 vaccine scores longer shelf life just as millions of doses were set to expire and more... |
| 2021-06-11 00:15 | | 80% of pharma workers think Aduhelm's approval was a mistake, survey says and more... |
| 2021-06-10 12:15 | | Five Collaborations Unlocking Faster Drug Development this Week and more... |
| 2021-06-10 00:15 | | US to send 500M Pfizer COVID-19 vaccines to 100 countries over next year and more... |
| 2021-06-09 12:15 | | Pfizer rolls out next-gen pneumococcal vaccine with FDA win, beating Merck's 15-valent candidate to the punch and more... |
| 2021-06-09 00:15 | | Member of FDA’s expert panel resigns over controversial Alzheimer’s therapy approval and more... |
| 2021-06-08 12:15 | | Hoping to challenge blockbuster breast cancer franchises, a small Dutch biotech says its ADC passed a PhIII test and more... |
| 2021-06-08 00:15 | | Biogen's 'shockingly broad' Aduhelm label—and $56K price—set up a $10B launch, analysts say and more... |
| 2021-06-07 12:15 | | U.S. FDA approves Biogen Alzheimer's drug and more... |
| 2021-06-07 00:15 | | A New Type Of COVID-19 Vaccine Could Debut Soon and more... |
| 2021-06-06 00:15 | | Novo Nordisk's semaglutide set to tackle obesity with hotly-anticipated FDA green light and more... |
| 2021-06-04 12:15 | | #ASCO21: Gilead's Trodelvy reads out new subgroup data showing benefit in earlier-line TNBC patients and more... |
| 2021-06-04 00:15 | | Bristol-Myers is sued for $6.4 billion over delayed cancer drug and more... |
| 2021-06-03 12:15 | | Independent from Merck, Organon CEO lays out newco's women's health ambitions, M&A plans and more... |
| 2021-06-03 00:15 | | Sanofi looks to take Mylan to court, again, over EpiPen antitrust allegations and more... |
| 2021-06-02 12:15 | | Moderna bags another US CDMO to help with fill-finish work for its vaccine amid booster push and more... |
| 2021-06-02 00:15 | | Immunovant flashes the data that made Roivant want to reacquire it at a potentially hefty premium and more... |
| 2021-06-01 12:15 | | Liminal stops plan to advance fibrosis drug after seeing PK data and more... |
| 2021-06-01 00:15 | | EU approves Pfizer/BioNTech COVID-19 vaccine for teens and more... |
